Publication | Closed Access

Late immune-related adverse events in long-term responders to PD-1/PD-L1 checkpoint inhibitors: A multicentre study

Cancer ImmunosurveillanceAutoimmune DiseaseMedicineMulticentre StudyImmunologyTumor ImmunityPd-1/pd-l1 Checkpoint InhibitorsImmune SurveillanceAutoimmunityLong-term RespondersImmune Checkpoint InhibitorImmunotherapyOncologyRadiation OncologyImmune Dysregulation